Literature DB >> 8104199

Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.

M J Berry1, D Grieco, B A Taylor, A L Maia, J D Kieffer, W Beamer, E Glover, A Poland, P R Larsen.   

Abstract

Inbred mouse strains differ in their capacity to deiodinate iododioxin and iodothyronines, with strains segregating into high or low activity groups. Metabolism of iododioxin occurs via the type I iodothyronine 5'deiodinase (5'DI), one of two enzymes that metabolize thyroxine (T4) to 3,5,3'-triiodothyronine (T3). Recombinant inbred strains derived from crosses between high and low activity strains exhibit segregation characteristic of a single allele difference. Hepatic and renal 5'DI mRNA in a high (C57BL/6J) and low (C3H/HeJ) strain paralleled enzyme activity and concentration, in agreement with a recent report. 5'DI-deficient mice had twofold higher serum free T4 but normal free T3 and thyrotropin. Brown adipose tissue 5'DII was invariant between the two strains. Southern analyses using a 5'DI probe identified a restriction fragment length variant that segregated with 5'DI activity in 33 of 35 recombinant inbred strains derived from four different pairs of high and low activity parental strains. Recombination frequencies using previously mapped loci allowed assignment of the 5'DI gene to mouse chromosome 4 and identified its approximate chromosomal position. We propose the symbol Dio1 to denote the mouse 5'DI gene. Conserved linkage between this segment of mouse chromosome 4 and human HSA1p predicts this location for human Dio1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104199      PMCID: PMC288298          DOI: 10.1172/JCI116730

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release.

Authors:  J E Silva; P R Larsen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

Review 2.  Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice.

Authors:  D L Coleman
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

3.  Mechanisms for the biodehalogenation of iodocompounds.

Authors:  J E Sinsheimer; T Wang; S Röder; Y Y Shum
Journal:  Biochem Biophys Res Commun       Date:  1978-07-14       Impact factor: 3.575

4.  Cerebral cortex responds rapidly to thyroid hormones.

Authors:  J L Leonard; M M Kaplan; T J Visser; J E Silva; P R Larsen
Journal:  Science       Date:  1981-10-30       Impact factor: 47.728

5.  Transcriptional control in the production of liver-specific mRNAs.

Authors:  E Derman; K Krauter; L Walling; C Weinberger; M Ray; J E Darnell
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

6.  Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine.

Authors:  J E Silva; P R Larsen
Journal:  Science       Date:  1977-11-11       Impact factor: 47.728

7.  Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.

Authors:  P R Larsen; T E Dick; B P Markovitz; M M Kaplan; T G Gard
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

8.  Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

9.  Comparison of the biological effects of thyroxine and triiodothyronine in the rat.

Authors:  P R Larsen; R D Frumess
Journal:  Endocrinology       Date:  1977-04       Impact factor: 4.736

10.  Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase.

Authors:  M J Berry; J D Kieffer; J W Harney; P R Larsen
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

View more
  22 in total

1.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.

Authors:  J H Duncan Bassett; Alan Boyde; Peter G T Howell; Richard H Bassett; Thomas M Galliford; Marta Archanco; Holly Evans; Michelle A Lawson; Peter Croucher; Donald L St Germain; Valerie Anne Galton; Graham R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 2.  The menace of endocrine disruptors on thyroid hormone physiology and their impact on intrauterine development.

Authors:  George Mastorakos; Eftychia I Karoutsou; Maria Mizamtsidi; George Creatsas
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

3.  Isolation of differentially expressed genes upon immunoglobulin class switching by a subtractive hybridization method using uracil DNA glycosylase.

Authors:  M Sugai; S Kondo; A Shimizu; T Honjo
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

4.  Strain distribution pattern for SSLP markers in the SWXJ recombinant inbred strain set: chromosomes 1 to 6.

Authors:  K L Svenson; Y C Cheah; K L Shultz; J L Mu; B Paigen; W G Beamer
Journal:  Mamm Genome       Date:  1995-12       Impact factor: 2.957

5.  Sex, genetics, and the control of thyroxine and thyrotropin in mice.

Authors:  Sandra M McLachlan; Sepehr Hamidi; Holly Aliesky; Robert W Williams; Basil Rapoport
Journal:  Thyroid       Date:  2014-05-22       Impact factor: 6.568

Review 6.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

7.  Selenoprotein gene expression during selenium-repletion of selenium-deficient rats.

Authors:  G Bermano; F Nicol; J A Dyer; R A Sunde; G J Beckett; J R Arthur; J E Hesketh
Journal:  Biol Trace Elem Res       Date:  1996-03       Impact factor: 3.738

Review 8.  Deiodinases: implications of the local control of thyroid hormone action.

Authors:  Antonio C Bianco; Brian W Kim
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

9.  Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X).

Authors:  Caterina Di Cosmo; Neil McLellan; Xiao-Hui Liao; Kum Kum Khanna; Roy E Weiss; Laura Papp; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

10.  Iodothyronine deiodinase enzyme activities in bone.

Authors:  Allan J Williams; Helen Robson; Monique H A Kester; Johannes P T M van Leeuwen; Stephen M Shalet; Theo J Visser; Graham R Williams
Journal:  Bone       Date:  2008-04-04       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.